
Sign up to save your podcasts
Or


Our co-hosts interview Drs. Kristin Higgins and Dr. Sue Yom on the results of NRG-LU005 (chemo +/- atezo in limited-stage small cell lung cancer) and NRG-HN005 (de-intensified RT for Early-stage p16+ oropharyngeal cancer) presented during the 2024 ASTRO Plenary Session.
By NRG Oncology5
1010 ratings
Our co-hosts interview Drs. Kristin Higgins and Dr. Sue Yom on the results of NRG-LU005 (chemo +/- atezo in limited-stage small cell lung cancer) and NRG-HN005 (de-intensified RT for Early-stage p16+ oropharyngeal cancer) presented during the 2024 ASTRO Plenary Session.

30,649 Listeners

43,765 Listeners

112,617 Listeners

56,472 Listeners

9,505 Listeners

6,445 Listeners

61 Listeners

3,000 Listeners

5,518 Listeners

9,909 Listeners

16,081 Listeners

10,892 Listeners

2,287 Listeners

189 Listeners

37 Listeners